Down modulation of human TLR3 function by a monoclonal antibody

Karen E Duffy1, Roberta J Lamb, Lani R San Mateo

  • 1Discovery Research, Centocor Research and Development, Inc., Malvern, PA 19355, USA. kduffy@cntus.jnj.com

Cellular Immunology
|December 1, 2007
PubMed
Summary

A new monoclonal antibody (mAb CNTO2424) neutralizes Toll-like receptor 3 (TLR3) signaling. This antibody blocks inflammatory cytokine production and interferes with key TLR3 pathways, offering a tool to study innate immunity.